UNSPSC 51284905: Methenamine/sodium biphosphate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM550. This VA Drug Class (AM550) classifies this compound as belonging to the group METHENAMINE SALTS ANTIMICROBIALS.

UNSPSC 51284905 Methenamine/sodium biphosphate is a Commodity code that state and local agencies use to classify pharmaceutical products, though the recent opportunities posted under this code show minimal relevance to the code's nominal scope. The Illinois Department of Public Health's MMCAP Infuse piggyback contract (solicitation 26482DPHPREPDB53392, awarded August 28, 2026) procured Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through competitive bidding, while Seminole County, Florida's IFB60459723LAS (posted June 30, 2026, response due July 26, 2023) sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually. Neither solicitation names methenamine/sodium biphosphate specifically; instead, they represent broader pharmaceutical procurement by state health and county public-health agencies through cooperative purchasing agreements and direct competitive bids. The code appears to reflect pharmaceutical warehouse and emergency-response product supply chains rather than a single drug formulation.

Activity under this code is limited and geographically sparse. Illinois and Florida account for the two identified recent opportunities, with one already awarded and the other dated to 2023, suggesting the code itself sees infrequent solicitation activity at the state and local level. The Illinois award to Chartwell Rx LLC totaled $2,999,999.11 over a three-year term (12-month initial plus two renewal years), reflecting large-volume pharmaceutical supply operations. Seminole County's procurement was structured for quarterly delivery and included FEMA-potential funding with associated federal compliance requirements. Neither jurisdiction imposed specific small-business or minority enterprise set-asides. The mismatch between the code's name and the work actually being bought suggests this code may not be the primary taxonomy used by most state and local procurement offices for pharmaceutical product categories, or the opportunities may be misclassified in the source system.